Latest Research Collaboration News

Page 4 of 9
Pure Resources has demonstrated that its Carbon Nanotube Fibre (CNTF) achieves thermal conductivity up to 600 W/m·K, outperforming copper by 1.5 times and aluminium by up to 3 times, positioning it as a breakthrough for AI, defence, and high-power electronics cooling.
Maxwell Dee
Maxwell Dee
5 May 2026
Nexsen Limited teams with Universiti Malaya to launch a joint research facility aiming to develop a rapid biosensor detecting E. coli and Salmonella simultaneously, addressing a critical food safety gap in Southeast Asia.
Ada Torres
Ada Torres
4 May 2026
4DMedical has made significant strides in commercial adoption of its CT:VQ™ lung imaging technology, securing top US hospital contracts, regulatory approvals in Europe and the UK, and a major pharmaceutical partnership, all backed by strong capital raises and inclusion in the S&P/ASX 200.
Ada Torres
Ada Torres
30 Apr 2026
Percheron Therapeutics has secured $2.2 million through an entitlement offer to fund the next stage of its HMBD-002 oncology program, with manufacturing underway and key data presentations lined up at major cancer conferences.
Ada Torres
Ada Torres
30 Apr 2026
Starpharma has confirmed FDA alignment for its DEP® HER2 first-in-human phase 1 trial, with preparations underway for a mid-2026 start. The biotech also progressed strategic partnerships, published promising data with Genentech, and reported a $14.1 million cash balance alongside rising Viraleze™ sales.
Ada Torres
Ada Torres
29 Apr 2026
Neurotech International has opened its first Phase 3 clinical site for NTI164 targeting Autism Spectrum Disorder, reported positive 90-day toxicology results, and launched a new Rett syndrome research collaboration.
Ada Torres
Ada Torres
29 Apr 2026
Paradigm Biopharmaceuticals has upsized a $14 million placement and launched a $2 million SPP, boosting its cash runway to around $45 million. This capital injection supports the ongoing Phase 3 trial for knee osteoarthritis, with interim results expected in Q3 2026.
Ada Torres
Ada Torres
27 Apr 2026
Pure Resources has launched a cutting-edge research collaboration with Rice University to develop carbon nanotube fibre thermal management systems, leveraging graphite from its Garnet Hills Project. The initiative is backed by a $3 million equity raise to fund exploration and downstream material innovation.
Maxwell Dee
Maxwell Dee
31 Mar 2026
Heavy Rare Earths Limited has confirmed the presence of valuable rare earth minerals Monazite and Xenotime at its Radium Hill Project, signalling new potential beyond historic uranium mining.
Maxwell Dee
Maxwell Dee
26 Mar 2026
BPH Global is expanding its seaweed biomass research to develop renewable biofuels like biohydrogen and biocrude, aiming to carve out a sustainable alternative to fossil fuels in energy and transport sectors.
Maxwell Dee
Maxwell Dee
17 Mar 2026
Neurotech International reports a dramatic reduction in half-year losses alongside significant clinical and regulatory progress for its lead cannabinoid therapy NTI164. The company also strengthens its cash position through a $4 million placement and a $4.7 million R&D tax refund.
Ada Torres
Ada Torres
26 Feb 2026
Prescient Therapeutics reported a 62.8% increase in half-year losses to nearly $4 million, driven by intensified clinical development of its PTX-100 cancer therapy. The company bolstered its balance sheet with a $9.85 million capital raise while securing key regulatory milestones in Europe and the US.
Ada Torres
Ada Torres
24 Feb 2026

Browse the archive

Full archive